S. Arebee, A. (2025). CRISPR Gene-Editing Therapies for Sickle Cell Disease and Beta- Thalassemia: Clinical Outcomes, Risks and Safety Profiles. A Systematic Review. Libyan Journal of Medical and Applied Sciences, 3(4), 102–108. https://doi.org/10.64943/ljmas.v3i4.254